Sientra Inc
Change company Symbol lookup
Select an option...
SIEN Sientra Inc
NOBL ProShares S&P 500 Dividend Aristocrats ETF
NLY Annaly Capital Management Inc
NGG National Grid PLC
NEM Newmont Corporation
NDP Tortoise Energy Independence Fund, Inc
NCV AllianzGI Convertible & Income Fund
NCV AllianzGI Convertible & Income Fund
NAC Nuveen California Quality Municipal Income Fund
MUC BlackRock MuniHoldings California Quality Fund, Inc.

Health Care : Health Care Equipment & Supplies | Small Cap Growth
Company profile

Sientra, Inc. is a medical aesthetics company. The Company's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 400 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. Its breast implants are primarily used in elective procedures, which are generally performed on a cash-pay basis. Implant Texture provides texturing on the implant shell that is designed to reduce the incidence of malposition, rotation and capsular contracture. The Company also offers breast tissue expanders and a range of other aesthetic and specialty products. The Company offers a range of HSC+ breast implants, including anatomically shaped textured, round textured and round smooth. The Company also offers miraDry system, the device to reduce underarm sweat, odor and permanently reduce hair of all colors.

Closing Price
Day's Change
-0.05 (-2.51%)
B/A Size
Day's High
Day's Low

10-day average volume:



7 providers
March 11, 2020
Sientra Reports Fourth Quarter and Full Year 2019 Financial Results

Achieves Record Fourth Quarter Net Sales and Strong Growth Across Both Business Segments Well-Capitalized Balance Sheet Provides Enhanced Flexibility to Execute on Strategic Initiatives Q4 and Full Year 2019 Highlights: (Globe Newswire)

Sientra Announces $60 Million Convertible Notes Investment from Deerfield Management

Sientra, Inc. (NASDAQ: SIEN) ("Sientra" or the "Company"), a diversified medical aesthetics company, today announced that it has closed a $60 million convertible notes financing with a fund managed by Deerfield Management Company L.P...(Globe Newswire)

Sientra, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 11, 2020 / Sientra, Inc. (NASDAQ:SIEN) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 11, 2020 at 5:00 PM Eastern Time. (Accesswire)

February 26, 2020
Sientra to Report 4Q19 Financial Results on March 11, 2020

Sientra, Inc. (Nasdaq: SIEN), a medical aesthetics company, announced today that it will release 4Q19 financial results after the close of trading on Wednesday, March 11, 2020. Sientra will host a conference call to discuss financial results the...(Globe Newswire)

February 20, 2020
Sientra to Present at the 9th Annual SVB Leerink Global Healthcare Conference

Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, announced today that members of management are scheduled to present at the 9 Annual SVB Leerink Global Healthcare Conference. An audio webcast of the Company's presentation will be made...(Globe Newswire)

February 19, 2020
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sientra, Inc. (NASDAQ: SIEN) ("Sientra" or the "Company"), a medical aesthetics company, today announced that on February 13, 2020, the Compensation Committee of the Board of Directors approved equity award grants under the Sientra Inc. Inducement...(Globe Newswire)

January 13, 2020
Sientra Announces Preliminary Unaudited 4Q19 Net Sales and Appointment of Caroline Van Hove to Board of Directors

Anticipates total fourth quarter net sales of $23.2 million, growth of 22% year over year Aesthetics industry executive Caroline Van Hove joins Sientra's Board of Directors Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, today announced...(Globe Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.